Tate & Lyle PLC Rating Reiterated by Jefferies Group (TATE)
Tate & Lyle PLC (LON:TATE)‘s stock had its “hold” rating restated by equities research analysts at Jefferies Group in a research note issued to investors on Friday. They currently have a GBX 685 ($11.34) price objective on the stock. Jefferies Group’s price target suggests a potential upside of 2.32% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Berenberg Bank reiterated a “buy” rating on shares of Tate & Lyle PLC in a research note on Wednesday, August 20th. They now have a GBX 775 ($12.82) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “hold” rating on shares of Tate & Lyle PLC in a research note on Monday, August 11th. They now have a GBX 640 ($10.59) price target on the stock. Finally, analysts at Societe Generale reiterated a “buy” rating on shares of Tate & Lyle PLC in a research note on Tuesday, July 29th. They now have a GBX 745 ($12.33) price target on the stock. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of GBX 746.88 ($12.36).
Shares of Tate & Lyle PLC (LON:TATE) traded up 0.45% during mid-day trading on Friday, hitting GBX 672.50. 579,360 shares of the company’s stock traded hands. Tate & Lyle PLC has a 1-year low of GBX 618.50 and a 1-year high of GBX 826.00. The stock’s 50-day moving average is GBX 663.9 and its 200-day moving average is GBX 669.2. The company’s market cap is £3.117 billion.
Tate & Lyle PLC is a global provider of ingredients and solutions to the food, beverage and other industries.
Receive News & Ratings for Tate & Lyle PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.